A 12-week, Multi-Center, Randomized Double-Blind, Active Control Parallel Group Study to Evaluate the Efficacy and Safety of the Combination of Valturna and Amlodipine or Valturna and Chlorthalidone Versus Valturna Alone in Patients With Stage 2 Hypertension and Diabetes
Phase of Trial: Phase IV
Latest Information Update: 18 Mar 2013
At a glance
- Drugs Aliskiren/valsartan (Primary) ; Amlodipine; Chlortalidone
- Indications Hypertension
- Focus Therapeutic Use
- Acronyms VALENCIA
- Sponsors Novartis
- 01 Jan 2012 Actual end date (Jan 2012) added as reported by ClinicalTrials.gov.
- 01 Jan 2012 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 10 Jun 2011 New trial record